THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
DelistedCIK 1419051fmd_0ENZ5MX7B73FWM189B67GKZ21NManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2024, 56 periods
Latest annual · FY2023
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (2)
- Net income
- (2)
- Free cash flow
- (1)
Latest quarter · Q3 FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (2)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +16.5%
- Revenue, 5 yearsFY2018 to FY2023
- +95.3%
- Net income, 5 yearsFY2018 to FY2023
- n/m
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $98,994 | $206,767 | -52.1% | 10-K 2024-04-17 · proof |
| Gross profit | $62,226 | $127,327 | -51.1% | 10-K 2024-04-17 · proof |
| Operating income | -$2 million | -$3.3 million | 10-K 2024-04-17 · proof | |
| Net income | -$2.2 million | -$3.8 million | 10-K 2024-04-17 · proof | |
| Cash from operating activities | -$1.1 million | -$1 million | 10-K 2024-04-17 · proof | |
| Free cash flow | -$1.1 million | 10-K 2024-04-17 · proof | ||
| Total assets | $3.3 million | $3.6 million | -8.7% | 10-K 2024-04-17 · proof |
| Total liabilities | $2 million | $2.2 million | -9.5% | 10-K 2024-04-17 · proof |
| Cash and cash equivalents | $27,823 | $18,434 | +50.9% | 10-K 2024-04-17 · proof |
- What was THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s revenue in fiscal 2023?
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported revenue of $98,994 for fiscal 2023 (the year ended Dec 31, 2023), against $206,767 the year before (-52.1%). Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
- What was THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s gross profit in fiscal 2023?
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported gross profit of $62,226 for fiscal 2023 (the year ended Dec 31, 2023), against $127,327 the year before (-51.1%). Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
- What was THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s operating income in fiscal 2023?
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported operating income of -$2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$3.3 million the year before. Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
- What was THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s net income in fiscal 2023?
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported net income of -$2.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$3.8 million the year before. Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
- What was THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s cash from operating activities in fiscal 2023?
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported cash from operating activities of -$1.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$1 million the year before. Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
- What was THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s free cash flow in fiscal 2023?
- THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported free cash flow of -$1.1 million for fiscal 2023 (the year ended Dec 31, 2023). Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
- What are THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s total assets?
- As of Dec 31, 2023, THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported total assets of $3.3 million, against $3.6 million a year earlier (-8.7%). Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
- What are THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s total liabilities?
- As of Dec 31, 2023, THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported total liabilities of $2 million, against $2.2 million a year earlier (-9.5%). Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
- What are THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.'s cash and cash equivalents?
- As of Dec 31, 2023, THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reported cash and cash equivalents of $27,823, against $18,434 a year earlier (+50.9%). Source: the 10-K filed with the SEC on Apr 17, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1419051&period_type=annual&limit=5"Information only, not investment advice.